Atlas Trials

A Bioequivalence Study of 15 mg ER OROS Paliperidone

Clinical trial NCT00892489 · COMPLETED

Trial details

NCT number
NCT00892489
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Schizophrenia
Start date
2004-07-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.